SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549 

 

SCHEDULE 13D

 

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2(a)

 

Startech Labs, Inc.

(Name of Issuer)

 

COMMON STOCK, PAR VALUE $0.001 PER SHARE

(Title of Class of Securities)

 

85571L103

(CUSIP Number)

 

KEVIN SO

10 area 9, Luzon Ave, Old Balara, Quezon City, Philippines

802 255 4212

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

 

March 26, 2020

(Date of Event Which Requires Filing of this Statement) 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  

 

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

 

1

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

(Continued on following pages)

(Page 1 of 3 pages) 

 

 
 

 

 

 

CUSIP NO. - 85571L103

 

2 OF 3 PAGES

 

  1 

NAMES OF REPORTING PERSONS

 

Kevin So

  2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ☐        (b)  ☐

 

  3

SEC USE ONLY

 

  4

SOURCE OF FUNDS

 

PF

  5

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  6

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Philippines

NUMBER OF

SHARES

 BENEFICIALLY  

OWNED BY

EACH

REPORTING

PERSON

WITH

   7 

SOLE VOTING POWER

 

55,000,000 shares of Common Stock owned directly and beneficially by Mr. So

   8  

SHARED VOTING POWER

 

0

   9  

SOLE DISPOSITIVE POWER

 

55,000,000 shares of Common Stock owned directly and beneficially by Mr. So

 10  

SHARED DISPOSITIVE POWER 

0

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

55,000,000 shares of Common Stock

12

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

99.73% of the outstanding shares of Common Stock

14

TYPE OF REPORTING PERSON

 

IN

   

 
 

 

 
 

CUSIP NO. - 85571L103

 

3 OF 3 PAGES

 

SIGNATURE 

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement on Schedule 13D is true, complete and correct. 

  

       
Dated: April 24, 2020 /s/ Kevin So

 

 

KEVIN SO  
     
       

 

 

 
 

 

 

 

Startech Labs (PK) (USOTC:LAAB)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Startech Labs (PK) Charts.
Startech Labs (PK) (USOTC:LAAB)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Startech Labs (PK) Charts.